id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-N-4732-0001,FDA,FDA-2025-N-4732,"Determination That ZANTAC (Ranitidine Hydrochloride) Injection, Equivalent to 25 Milligrams Base/
Milliliter, Has Not Been Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2025-12-12T05:00:00Z,2025,12,2025-12-12T05:00:00Z,,2025-12-12T19:55:43Z,2025-22676,0,0,09000064b90c85aa